HYDROCHLOROTHIAZIDE; VALSARTAN | A206083 | PRINSTON PHARMACEUTICAL INC
Highest NADAC/Unit
$0.2007
per ea
Lowest NADAC/Unit
$0.1002
per ea
Brand NDCs
0
Generic NDCs
5
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 43547031509VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB | $0.2007 | EA | Generic | — | 2026-08-19 |
| 43547031409VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB | $0.1911 | EA | Generic | — | 2026-08-19 |
| 43547031309VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB | $0.1245 | EA | Generic | — | 2026-08-19 |
| 43547031209VALSARTAN-HYDROCHLOROTHIAZIDE 160-12.5 MG TAB | $0.1027 | EA | Generic | — | 2026-08-19 |
| 43547031109VALSARTAN-HYDROCHLOROTHIAZIDE 80-12.5 MG TAB | $0.1002 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.